CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behçet's uveitis

Journal of Immunology

Volumn 175, Issue 9, 2005, Pages 6133-6142

  Ahn, Jae Kyoun ^a   Chung, Hum ^a   Lee, Dong Sup ^b   Yu, Young Suk ^a   Yu, Hyeong Gon ^a,c  

^a Seoul National University Biomedical Research Institute   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BREFELDIN A; CD11B ANTIGEN; CD27 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; COLCHICINE; CONCANAMYCIN A; CYCLOSPORIN; FAS ANTIGEN; GAMMA INTERFERON; IONOMYCIN; NATURAL KILLER CELL RECEPTOR NKG2D; NONSTEROID ANTIINFLAMMATORY AGENT; PADGEM PROTEIN; PERFORIN; PREDNISONE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; FAS LIGAND; FASLG PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; NATURAL KILLER CELL ACTIVATING RECEPTORS; PORE FORMING CYTOTOXIC PROTEIN; TUMOR NECROSIS FACTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BEHCET DISEASE; BLINDNESS; CELL STRAIN K 562; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DISEASE ACTIVITY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; RETINA VASCULITIS; T LYMPHOCYTE; UMBILICAL VEIN; UPREGULATION; UVEITIS; BIOSYNTHESIS; CELL CULTURE; CELL POLARITY; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; ANTIGENS, CD56; BEHCET SYNDROME; CELL POLARITY; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIAL CELLS; FAS LIGAND PROTEIN; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTORS;

EID: 27144435475     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.9.6133     Document Type: Article

References (49)

1. Hasan, A., F. Fortune, A. Wilson, K. Warr, T. Shinnick, Y. Mizushima, R. van der Zee, M. R. Standford, J. Sanderson, and T. Lehner. 1996. Role of γδ T cells in the pathogenesis and diagnosis with Behçet's disease. Lancet 347: 789-794.
2. Frassanito, M. A., R. Dammacco, P. Cafforio, and F. Dammacco. 1999. Th1 polarization of the immune response in Behçet's disease: a putative pathogenic role of interleukin-12. Arthritis Rheum. 42: 1967-1974.
3. Takeno, M., A. Kariyone, N. Yamashita, M. Takeuchi, Y. Mizushima, and H. Kaneko. 1995. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum. 38: 426-433.
4. + T cells. Curr. Opin. Immunol. 13: 465-470.
5. Snyder, M. R., C. M. Weyand, and J. J. Goronzy. 2004. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol. 25: 25-32.
6. Lanier, L. L., R. Testi, J. Bindl, and J. H. Phillips. 1989. Identification of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med. 169: 2233-2238.
7. + β cells by HLA-restricted and non-HLA-restricted pathways. Hum. Immunol. 63: 256-270.
8. Satoh, M., S. Seki, W. Hashimoto, K. Ogasawara, T. Kobayashi, K. Kumagai, S. Matsuno, and S. Takeda. 1996. Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J. Immunol. 157: 3886-3892.
9. + T cells closely correlates with CD56 surface expression. J. Immunol. 164: 1148-1152.
10. + T cells. Immunology 103: 281-290.
11. + T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis. Clin. Exp. Immunol. 137: 437-443.
12. + T cells after combined low dose cyclosporine and prednisone treatment in active Behçet's uveitis patients. Invest. Ophthalmol. Vis. Sci. 46: 2458-2464.
13. + T cells. J. Exp. Med. 186: 1407-1418.
14. Kagi, B., K. Ledermann, and R. Burki. 1994. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14: 207-232.
15. Kataoka, T., N. Shinohara, H. Takayama, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156: 3678-3686.
16. Roth, E., and H. Pircher. 2004. IFN-γ promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J. Immunol. 172: 1588-1594.
17. International Study Group for Behçet's disease. 1990. Criteria for diagnosis of Behçet's disease. Lancet 335: 1078-1080.
18. Bloch-Michel, E., and R. B. Nussenblatt. 1987. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am. J. Ophthalmol. 103: 235-236.
19. Jung, T., U. Schauer, C. Heusser, C. Neumann, and C. Rieger. 1993. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159: 197-207.
20. Pervin, K., A. Childerstone, T. Shinnick, Y. Mizushima, R. van der Zee, A. Hasan, R. Vaughan, and T. Lehner. 1993. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J. Immunol. 151: 2273-2282.
21. de Smet, M. D., and M. Dayan. 2000. Prospective determination of T cell responses to S-antigen in Behçet's disease patients and controls. Invest. Ophthalmol. Vis. Sci. 41: 3480-3484.
22. Lehner, T., E. Lavery, R. Smith, R. van der Zee, Y. Mizushima, and T. Shinnick. 1991. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's disease. Infect. Immunol. 59: 1434-1441.
23. Mizuki, N., M. Ota, Y. Katsuyama, K. Yabuki, H. Ando, G. D. Palimeris, A. Kaklamini, M. Accoritini, P. Pivetti-Pezzi, S. Ohno, and H. Inoko. 2000. Localization of the pathogenic gene of Behçet' s disease by microsatellite analysis of three different populations. Invest. Ophthalmol. Vis. Sci. 41: 3702-3708.
24. + cytotoxic T lymphocytes to major histocompatibility complex class 1 chain-related gene A in patients with Behçet's disease. Arthritis Rheum. 50: 3658-3662.
25. Mochizuki, M., E. Morita, S. Yamamoto, and S. Yamana. 1997. Characteristics of T cell lines established from skin lesions of Behçet's disease. J. Dermatol. Sci. 15: 9-13.
26. Gul, A., S. Esin, N. Dilsen, M. Konice, H. Wigzell, and P. Biberfeld. 1995. Immunohistology of skin pathergy reaction in Behçet's disease. Br. J. Dermatol. 132: 901-907.
27. Streilein, J. W. 1999. Immunoregulatory mechanisms of the eye. Prog. Retin. Eye Res. 18: 357-370.
28. Direskeneli, H. 2001. Behçet's disease: infectious etiology, new autoantigens, and HLA-B51. Ann. Rheum. Dis. 60: 996-1002.
29. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naïve CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161: 5338-5346.
30. + T cells from a memory to memory/effector phenotype. J. Immunol. 168: 5538-5550.
31. Houman, H., A. Hamzaoui, I. Ben Ghorbal, M. S. Khanfir, M. Feki, and K. Hamzaoui. 2004. Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease. Mediators Inflamm. 13: 247-253.
32. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195: 893-905.
33. + memory T cell subsets in response to antigen or homeostatic cytokines. Blood 101: 4260-4266.
34. + T cells. Proc. Natl. Acad. Sci. USA 95: 1172-1177.
35. Speiser, D. E., M. J. Pittet, D. Valmori, R. Dunbar, D. Rimoldi, D. Lienard, H. R. MacDonald, J. C. Cerottini, V. Cerundolo, and P. Romero. 1999. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 190: 775-782.
36. + T cells. J. Immunol. 169: 1444-1452.
37. + T cells. J. Immunol. 169: 693-701.
38. + T cell responses. Nat. Immunol. 3: 189-195.
39. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Philips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
40. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8 αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2: 255-260.
41. Mizuki, N., M. Ota, M. Kimura, S. Ohno, H. Ando, Y. Katsuyama, M. Yamazaki, K. Watanabe, K. Goto, S. Nakamura, et al. 1997. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet's disease. Proc. Natl. Acad. Sci. USA 94: 1298-1303.
42. Sugi-Ikai, N., M. Nakazawa, S. Nakamura, S. Ohno, and M. Minami. 1998. Increased frequencies of interleukin-2 and interferon γ producing T cells in patients with active Behçet's disease. Invest. Ophthalmol. Vis. Sci. 39: 996-1004.
43. McDyer, J. F., T. J. Goletz, E. Thomas, C. H. June, and R. A. Seder. 1998. CD40 ligand/CD40 stimulation regulates the production of IFN-γ from human peripheral blood mononuclear cells in an IL-12 and/or CD28-dependent manner. J. Immunol. 160: 1701-1707.
44. Russell, J. H., and T. J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20: 323-370.
45. + T cells. Immunology 108: 211-219.
46. Lee, K. H., H.-S. Chung, H. S. Kim, S.-H. Oh, M.-K. Ha, J.-H. Baik, S. Lee, and D. Bang. 2003. Human α-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum. 48: 2025-2035.
47. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91: 4185-4189.
48. Mullbacher, A., M. Lobigs, R. T. Hla, T. Tran, T. Stehle, and M. M. Simon. 2002. Antigen-dependent release of IFN-γ by cytotoxic T cells up-regulates Fas on target cells and facilitates exocytosis-independent specific target cell lysis. J. Immunol. 169: 145-150.
49. APO-1/Fas and procaspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am. J. Pathol. 161: 1485-1495.